anybody watching merck's deal with agenus? seems to be some interesting parallels. agenus able to receive royalties to around $100 million in addition to waypoint payments for certain clinical checkpoints. interesting. agen shot up .50 yesterday in response to all the going's on. this is a great deal for agen that mirrors what could happen with oncs. I'd gladly take the half a buck right now. with oncs, though, there is much more in the clinical pipeline so any partnership should bring even more. onward and upward!!!